EcoDrugPlus

Ribosomal Protein L5b

Ensembl ID : ENSDARG00000015862
Gene Symbol: RPL5B
12 Enzyme and pathways 5 Cross references
448 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSDARG00000058451
Gene Symbol: RPL6
12 Enzyme and pathways 5 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSDARG00000007320
Gene Symbol: RPL7
12 Enzyme and pathways 5 Cross references
492 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSDARG00000014867
Gene Symbol: RPL8
12 Enzyme and pathways 5 Cross references
278 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSDARG00000037350
Gene Symbol: RPL9
5 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSDARG00000034897
Gene Symbol: RPS10
19 Enzyme and pathways 5 Cross references
385 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSDARG00000053058
Gene Symbol: RPS11
19 Enzyme and pathways 5 Cross references
284 Possible Orthologues:

Ribosomal Protein S11b

Ensembl ID : ENSDARG00000093606
Gene Symbol: RPS11B
5 Cross references
281 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSDARG00000036875
Gene Symbol: RPS12
19 Enzyme and pathways 5 Cross references
401 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSDARG00000036298
Gene Symbol: RPS13
19 Enzyme and pathways 5 Cross references
381 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSDARG00000036629
Gene Symbol: RPS14
19 Enzyme and pathways 5 Cross references
330 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSDARG00000070849
Gene Symbol: RPS15
19 Enzyme and pathways 5 Cross references
339 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).